Pricing Log in Create free account

aTyr Pharma, Inc. (ATYR) vs Jasper Therapeutics, Inc. (JSPR)

aTyr Pharma, Inc. and Jasper Therapeutics, Inc. are both Biotechnology companies. aTyr Pharma, Inc. and Jasper Therapeutics, Inc. are of similar size ($18.0M and $17.7M). Across the 10 metrics below, aTyr Pharma, Inc. leads on 6 and Jasper Therapeutics, Inc. on 4.

Valuation

Metric ATYR JSPR Biotechnology median
P/E n/m n/m 8.50
P/S 1.49 n/m 9.71
P/B 0.34 9.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.59 n/m 0.64
EV/Sales (3.37) n/m 9.21
Earnings yield (364.71%) (331.25%) (33.15%)
Free cash flow yield (328.74%) (437.42%) (25.50%)

Profitability

Metric ATYR JSPR Biotechnology median
Gross margin 1.72% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) (255.05%) (56.36%)
Return on assets (70.97%) (109.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATYR JSPR Biotechnology median
Revenue growth (TTM) 6.78% — 6.02%
EPS growth (last fiscal year) 6.98% 19.22% 30.26%
Revenue growth, 5-year CAGR (14.75%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR JSPR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.12 1.48 4.72
Net debt to EBITDA 1.01 0.35 0.96

Dividend

Metric ATYR JSPR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATYR JSPR Biotechnology median
Market cap 18.03m 17.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack